Federal health officials are halting mRNA vaccine investments, citing controversial studies. Experts express alarm over potential impacts on public health progress.
In a surprising move, U.S. health officials have canceled $500 million in mRNA vaccine research, citing studies that question their safety and effectiveness. Critics warn this decision undermines vital public health advancements made during the pandemic.